RHYTHM PHARMACEUTICALS, INC. (RYTM) [Rocket]

Overview

RHYTHM PHARMACEUTICALS, INC. (RYTM)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
08/21/2023	8-K	Other Events  Interactive Data
08/16/2023	3	German Christopher Paul (Corporate Controller & CAO) has filed a Form 3 on RHYTHM PHARMACEUTICALS, INC.
08/09/2023	4	Lee Jennifer Kayden (EVP, Head of North America) has filed a Form 4 on RHYTHM PHARMACEUTICALS, INC.
08/09/2023	144	Form 144 - Report of proposed sale of securities:
08/08/2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/07/2023	144	Form 144 - Report of proposed sale of securities:
08/03/2023	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-22	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15
Revenues	23.6	3.2	0.0	0.0	0.0	0.0	2.7	3.4
Revenue growth	649.5%					-100.0%	-20.6%
Cost of goods sold	2.1	0.6	0.0	0.0	0.0	0.0	2.7	3.4
Gross profit	21.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0
Gross margin	91.0%	81.0%					0.0%	0.0%
Selling, general and administrative	92.0	68.5	46.1	36.6	28.1	9.5	6.3	3.4
Research and development	108.6	104.1	90.5	109.5	50.3	22.9	19.6	7.1
EBITA	-178.4	-169.7	-136.6	-146.0	-78.4	-32.4	-25.9	-10.6
EBITA margin	-754.6%	-5381.0%					-949.9%	-307.8%
Amortization of intangibles	0.8	0.3
EBIT	-179.2	-170.1	-136.6	-146.0	-78.4	-32.4	-25.9	-10.6
EBIT margin	-757.9%	-5391.9%					-949.9%	-307.8%
Pre-tax income	-181.1	-69.6	-134.0	-140.7	-74.1	-33.7	-25.9	-11.1
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-181.1	-69.6	-134.0	-140.7	-74.1	-37.6	-29.1	-12.0
Net margin	-766.2%	-2207.1%					-1066.2%	-349.3%

Diluted EPS	($3.47)	($1.40)	($3.04)	($3.86)	($2.39)	($2.83)	($2.85)	($1.18)
Shares outstanding (diluted)	52.1	49.6	44.1	36.4	31.0	13.3	10.2	10.2

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.